Inhibikase Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $74k | 46k | 1.62 |
| 2025-06-30 | $75k | 38k | 1.95 |
| 2025-03-31 | $365 | 167 | 2.19 |
| 2024-12-31 | $543 | 167 | 3.25 |
| 2024-09-30 | $216 | 167 | 1.30 |
| 2024-06-30 | $202 | 167 | 1.21 |
| 2024-03-31 | $447 | 207 | 2.16 |
| 2023-12-31 | $255 | 201 | 1.27 |
| 2023-09-30 | $323 | 232 | 1.39 |
| 2023-06-30 | $705 | 196 | 3.60 |